Anti‐musk antibody myasthenia gravis: Clinical findings and response to treatment in two large cohorts

Abstract

MuSK-MG has a marked female predominance with frequent oculobulbar weakness and crises. Many patients deteriorate rapidly early in the disease, and PLEX is usually the preferred treatment. Long-term outcomes are similar to those of patients with AChR-Ab(+) MG.